Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

Leveraging global health resources requires on-the-ground knowledge and deep understanding of what motivates the public... See more
Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15... See more
Almost 10% of the US population lives with diabetes – that’s 30 million people, with another 84 million diagnosed with... See more
Burnout is afflicting more than half the physicians in the United States, according to the National Academy of Medicine... See more
Many clinicians have first-hand knowledge of what happens when their patients are unable to obtain the medications they... See more
Once considered a boutique enterprise, design thinking is no longer a luxury available only to a select few in the... See more

Pages